Market Update: Covidien plc (NYSE:COV) – Covidien SonicisionTM Portfolio Expansion Enables Surgeons to Choose Ideal Cordless Ultrasonic Dissection Device for Each Patient and Procedure
September 18, 2014 at 07:30 AM EDT
[Business Wire] – Covidien plc today announced the expansion of its Sonicision™ Cordless Ultrasonic Dissection Device portfolio, following U.S. Food and Drug Administration 510 clearance of three additional device lengths: 13 cm, 26 . . . → Read More: Market Update: Covidien plc (NYSE:COV) – Covidien SonicisionTM Portfolio Expansion Enables Surgeons to Choose Ideal Cordless Ultrasonic Dissection Device for Each Patient and Procedure Similar Articles: Company Update (NYSE:COV): Covidien Announces Start of Enrollment in Two Neurovascular Clinical Trials Company Update (NYSE:COV): Covidien Acquires Reverse Medical Corporation Company Update: Covidien plc (NYSE:COV) – Covidien Opens Advanced Medical Technology Center in Brazil